About us

Board of Directors

We know what it takes to bring physical touch to cancer diagnostics.

CO-FOUNDER/CEO

Jean Pham, M.S.

Senior Advisor

Mohan Iyer, MBA.

Independent Board Member

Lena Chaihorsky

Jesse Salk

Deborah Zajac

Advisory Board

Cellens is also supported by an exceptional team of scientific and industry advisors

SCIENTIFIC CO-FOUNDER

Igor Sokolov, Ph.D.

Senior Advisor

Anh Hoang-Lindsay, Ph.D.

Senior Advisor

Ryan Phan

Senior Advisor

Don Hardison

Senior Advisor

Michael Singer, M.D., Ph.D.

Intellectual Property Advisor

Ling Cheung Hughes, J.D.

Finance and Accounting Advisor

Art Healey, J.D.

Medical Scientific Advisor

Dr. Louis Liou, M.D., Ph.D.

Medical Scientific Advisor

Dr. Matthew Mossanen, M.D.

Medical Scientific Advisor

Dr. Haihui Liao, M.D., Ph.D.

Our Team

Cellens is also supported by an exceptional team of scientific and industry advisors

CO-FOUNDER/CEO

Jean Pham, M.S.

HEAD OF BIOPHYSICS R&D

Amir Monemian, Ph.D.

HEAD OF SOFTWARE ENGINEERING

Son Pham, M.S

R&D ENGINEER

Bao Pham

R&D ENGINEER

Gabrielle Blake

R&D ENGINEER

Nathaniel Trofimow

R&D LAB ASSOCIATE

Alex Beaudoin

Our Story

2020

Cellens, Inc. was founded as a Tufts University spinout based on research from Dr. Igor Sokolov’s laboratory. Dr. Sokolov had demonstrated the feasibility of using atomic force microscopy and machine learning for detection of cervical cancer, colon cancer and bladder cancer. Ms. Jean Pham co-founded Cellens Inc. with Dr. Sokolov to translate this cutting-edge technology into a clinically meaningful diagnostic platform.

2022

In 2022, Cellens Inc. entered into an exclusive license agreement with Tufts University and simultaneously received a Notice of Allowance from the USPTO for one of its foundational patents. That same year, Dr. Amir Monemian and Dr. Nadia Makarova joined the core team as full-time Lead Scientist and Biophysics Engineer, respectively.